Invention Grant
- Patent Title: TRPV4 antagonists
-
Application No.: US16334410Application Date: 2017-09-20
-
Publication No.: US10590077B2Publication Date: 2020-03-17
- Inventor: Edward J. Brnardic , Carl A. Brooks , Brian W. Budzik , Brian Griffin Lawhorn , Jay M. Matthews , John Jeffrey McAtee , Joseph E. Pero , David J. Behm
- Applicant: GlaxoSmithKline Intellectual Property (No.2) Limited
- Applicant Address: GB Brentford, Middlesex
- Assignee: GlaxoSmithKline Intellectual Property Development Limited
- Current Assignee: GlaxoSmithKline Intellectual Property Development Limited
- Current Assignee Address: GB Brentford, Middlesex
- Agent Wayne J. Dustman; Fang Qian
- International Application: PCT/IB2017/055703 WO 20170920
- International Announcement: WO2018/055527 WO 20180329
- Main IPC: A61K31/40
- IPC: A61K31/40 ; A61K31/695 ; A61K31/407 ; A61K31/501 ; A61K31/4439 ; A61K31/429 ; A61K31/4155 ; A61K31/427 ; A61K31/4025 ; A61K31/506 ; A61K31/4245 ; A61K31/424 ; A61K31/5386 ; A61K45/06 ; C07D491/107 ; C07D401/12 ; C07D513/04 ; C07D417/12 ; C07D409/12 ; C07D403/12 ; C07D413/12 ; C07D207/48 ; C07D498/10 ; A61P9/04 ; A61P11/14
Abstract:
The present invention relates to pyrrolidine sulfonamide analogs, pharmaceutical compositions containing them and their use as TRPV4 antagonists.
Public/Granted literature
- US20190202784A1 TRPV4 ANTAGONISTS Public/Granted day:2019-07-04
Information query
